There's the question as to why London and New York City would've had such an outlying increase in reported deaths that spring. I'm not aware of any other metropolis globally that reported a similar increase.
See first bullet in my updates to the post. How in the world did London's OHCA event start at the same time as New York's? Londoners were triggered by the words of Donald Trump?
Meanwhile, Chicago didn't see an OHCA event like that.
According to this data set, up to 79% of Covid deaths in London occurred in hospitals (for 2020), compared to 44% for all cause. Both Covid and all cause deaths start to peak in March, ie in line with the pandemic declaration.
You know what else is weird (and something I now remember commenting on to someone when the Sy study was published)? London's lower doses of Midazolam compared to its death increase
See Table 4: Midazolam Injections and Regional Excess Deaths for March/April and corresponding interpretation 2020https://www.researchgate.net/publication/377266988_Excess_Deaths_in_the_United_Kingdom_Midazolam_and_Euthanasia_in_the_COVID-19_Pandemic
"Compared to regional baselines calculated from 2015-2019 monthly averages (see Table 2), London region had tripled (300 percent) its expected all-cause mortality, while most other regions had approximately doubled (200 percent) their respective expected all-cause mortality. Such rapid, temporally concentrated and uniformly distributed deaths across England were unlikely to be caused naturally by an infectious disease.
Indeed, the Midazolam dose-to-death relationships were very similar across all regions, further supporting the supposed role of Midazolam in a UK systemic policy of euthanasia.
Some regions such as London, East, North West and Midlands had less than one dose per excess death, which suggests that Midazolam was not uniformly applied in all cases and that Midazolam was not the only sedative used in the euthanasia, particularly in the London region.
For example, along with many other drugs, Levomepromazine hydrochloride which is a sedative as well as an anti-psychotic drug, also had a surge in usage in UK [25] at about same time.
Another possible reason for why the London region had relatively high excess deaths compared to the registered doses of Midazolam may be due to selection bias by sick patients. It is possible that many sick patients from other regions may have sought specialist treatment from major London hospitals and clinics, which may have to use other sedatives due to limited supplies of Midazolam. The London outlier statistics may be another example of Simpson’s Paradox where a subpopulation may have confounding factors including selection bias, violating a statistical property which is valid only for the whole population or for other subpopulations."
There's the question as to why London and New York City would've had such an outlying increase in reported deaths that spring. I'm not aware of any other metropolis globally that reported a similar increase.
Madrid and Manaus https://x.com/Wood_House76/status/1784947778197627292
And provinces in N. Italy.
See first bullet in my updates to the post. How in the world did London's OHCA event start at the same time as New York's? Londoners were triggered by the words of Donald Trump?
Meanwhile, Chicago didn't see an OHCA event like that.
According to this data set, up to 79% of Covid deaths in London occurred in hospitals (for 2020), compared to 44% for all cause. Both Covid and all cause deaths start to peak in March, ie in line with the pandemic declaration.
https://data.london.gov.uk/dataset/coronavirus--covid-19--deaths
Weeks 11-18 of 2020 shows the death spike from Covid, just like NYC.
You know what else is weird (and something I now remember commenting on to someone when the Sy study was published)? London's lower doses of Midazolam compared to its death increase
See Table 4: Midazolam Injections and Regional Excess Deaths for March/April and corresponding interpretation 2020https://www.researchgate.net/publication/377266988_Excess_Deaths_in_the_United_Kingdom_Midazolam_and_Euthanasia_in_the_COVID-19_Pandemic
"Compared to regional baselines calculated from 2015-2019 monthly averages (see Table 2), London region had tripled (300 percent) its expected all-cause mortality, while most other regions had approximately doubled (200 percent) their respective expected all-cause mortality. Such rapid, temporally concentrated and uniformly distributed deaths across England were unlikely to be caused naturally by an infectious disease.
Indeed, the Midazolam dose-to-death relationships were very similar across all regions, further supporting the supposed role of Midazolam in a UK systemic policy of euthanasia.
Some regions such as London, East, North West and Midlands had less than one dose per excess death, which suggests that Midazolam was not uniformly applied in all cases and that Midazolam was not the only sedative used in the euthanasia, particularly in the London region.
For example, along with many other drugs, Levomepromazine hydrochloride which is a sedative as well as an anti-psychotic drug, also had a surge in usage in UK [25] at about same time.
Another possible reason for why the London region had relatively high excess deaths compared to the registered doses of Midazolam may be due to selection bias by sick patients. It is possible that many sick patients from other regions may have sought specialist treatment from major London hospitals and clinics, which may have to use other sedatives due to limited supplies of Midazolam. The London outlier statistics may be another example of Simpson’s Paradox where a subpopulation may have confounding factors including selection bias, violating a statistical property which is valid only for the whole population or for other subpopulations."